Syndax Pharmaceuticals (SNDX) Options Chain & Prices $20.62 -0.76 (-3.55%) As of 12:21 PM Eastern Add Compare Share Share Options Chain Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SNDX Put and Call Options List 1/21/2028 1/15/2027 10/16/2026 9/18/2026 8/21/2026 7/17/2026 6/18/2026 5/15/2026 Options Date Put and Call Options Put Options Call Options Options Type All In The Money Out of The Money Moneyness With Volume Without Volume All Volume Strike Price Min Strike Price Max Export ExpiresStrike PriceClose PricePut/CallVolumeVolume AskVolume BidOpen InterestImplied VolatilityDeltaTrades5/15/2026$19.00$0.165Put112 - 1001008(+5)107.08% (+14.03%)-0.13155135/15/2026$20.00$1.830Call10 - - 40(+10)109.74% (+16.31%)0.74376615/15/2026$21.00$0.824Put21117(+0)115.13% (+20.86%)-0.41152525/15/2026$21.00$1.250Call60 - 1070(+10)115.13% (+20.86%)0.59037325/15/2026$22.00$1.419Put61166(+0)121.85% (+26.45%)-0.55753645/15/2026$22.00$0.845Call2,6202562,2423800(+3737)121.85% (+26.45%)0.4449252185/15/2026$23.00$0.573Call293 - 29327(+7)128.98% (+32.24%)0.3264655/15/2026$24.00$0.393Call1411394(+1)136.03% (+37.86%)0.2371993End-of-day options data provided by Trade Alert and Intrinio. Related Companies and Tools Related Companies ACLX Options KYMR Options PTGX Options COGT Options MIRM Options CNTA Options CGON Options RYTM Options GRFS Options SRRK Options Options Chain Tools Short Interest TrackerShort Interest IncreasesShort Interest DecreasesUnusual Call VolumeUnusual Put Volume This page (NASDAQ:SNDX) was last updated on 5/12/2026 by MarketBeat.com Staff. From Our PartnersBSEM: From OTC to Nasdaq Contender!BioStem Technologies (OTC: BSEM) has posted seven consecutive profitable quarters and just released audited fi...Huge Alerts | SponsoredYale just did the math (you owe Washington $1,500)The Yale Budget Lab calculated that current U.S. trade policy is costing the average American household betwee...Priority Gold | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredIs $24 trillion about to move?Bloomberg reports that S-P Dow Jones Indices is considering rule changes that could fast-track SpaceX into the...The Oxford Club | SponsoredSpaceX Launches Strange 'Dark Energy' Across AmericaSpaceX is deploying a newly permitted energy technology - one that analyst Joel Litman calls 'Dark Energy' - t...Altimetry | SponsoredRead this or regret it foreverThree Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” P...Porter & Company | SponsoredIran broke the petrodollar…For 50 years, every barrel of oil settled in dollars - that rule is what made the dollar the world's reserve c...Golden Portfolio | SponsoredPeptide Company Lands Exclusive MMA Wellness PartnershipA publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform t...The Tomorrow Investor | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Syndax Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Syndax Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
